Form 4: PACS Group Director Granted 4,399 Restricted Stock Units

PACS Group Director Jacqueline Millard was granted 4,399 restricted stock units, aligning her interests with shareholders.

Summary

• Jacqueline Millard, a Director of PACS Group, Inc., acquired 4,399 Restricted Stock Units (RSUs) on December 19, 2025.
• Each RSU entitles the Reporting Person to receive one share of Common Stock upon vesting.
• The RSUs will vest 100% on the earlier of December 19, 2026, or the date of the next annual meeting following the grant date, contingent on continued service to the Issuer.
• Following this transaction, Jacqueline Millard beneficially owns 11,270 shares of Common Stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: Slightly positive, as it represents routine equity compensation for a director, aligning their interests with shareholders. It is not a significant market-moving event but reflects standard corporate governance.

Positives

• The grant of 4,399 Restricted Stock Units to a Director aligns management's interests with those of shareholders, promoting long-term value creation.
• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-arranged and transparent equity compensation strategy.

Future Outlook

The granted Restricted Stock Units are scheduled to vest on the earlier of December 19, 2026, or the date of the next annual meeting following the grant date, provided the Director continues her service to the Issuer.

Industry Context

The grant of Restricted Stock Units is a common form of equity compensation for directors in publicly traded companies, aiming to incentivize long-term performance and align their financial interests with those of shareholders. This practice is standard across various industries.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) for director compensation is a widely adopted practice across U.S. public companies, including those in the healthcare services sector where PACS Group operates. Companies like Ensign Group (ENSG) and Genesis Healthcare (GEN) also utilize equity-based compensation to align director incentives with shareholder value.
• The vesting schedule, tied to continued service and a specific future date or the next annual meeting, is typical for RSU grants to non-employee directors, ensuring retention and commitment.

Stakeholder Impact

• Shareholders: The RSU grant aligns the Director's financial interests with long-term shareholder value, potentially fostering more shareholder-centric decision-making.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• Vesting of the 4,399 Restricted Stock Units on the earlier of December 19, 2026, or the date of the next annual meeting following the grant date, subject to continued service.

Key Dates

Keywords

PACS Group, PACS, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, Equity Grant, Corporate Governance, Form 4